ST Pharm
ST Pharm
  • 01Who we are
  • 02Our record
  • 03Newsroom
  • 04Contact
    • En
    • Ko
ST Pharm
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
Public
ST PHARM News
  • PR (Public Relations)
    • News room
      • All
      • Media Focus
      • ST PHARM News
  • IR (Investor Relations)
    • Stock Information
    • IR Library
      • Disclosure Information
      • IR Materials
      • Notice

ST PHARM's Public Release

  • All
  • Media Focus
  • ST PHARM News
ST PHARM NewsST PHARM, Awarded 2022 Asia-Pacific Oligonucleotide CDMO Campany by Frost & SullivanMay 2, 2022
ST PHARM NewsST PHARM, participated in TIDES USA 2022 conference as a gold sponsorMay 2, 2022
ST PHARM NewsST Pharm to Expand Oligonucleotide FacilityNov 29, 2021
ST PHARM NewsST Pharm announces expansion of oligonucleotide facility, taking a leap towards the world's largest oligonucleotide CDMONov 29, 2021
ST PHARM NewsST PHARM Announces Publication of Preclinical Data for HIV-1 / AIIDS Treatment Drug 'STP0404'Jul 22, 2021
ST PHARM NewsST PHARM, the first company developing mRNA-LNP vaccine in South KoreaJun 1, 2021
1of1
HOMEPublicPR (Public Relations)News roomST PHARM News
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
© 2022 ST Pharm. All rights reserved.
  • Sitemap
  • Contact